Professor Isaac Odame, who specialises as a Pediatrician advocates for the state to absorb the cost of Hydroxyurea treatment for Sickle Cell patients in Ghana.
This will make the treatment for Sickle Cell disease accessible to all patients across the country according to Professor Odame. He made the call during a public lecture at the 8th Konuah, Halm-Addo, Awuletey, Alema Memorial Lecture which was held at the K.G Konuah Hall at the Accra Academy.
Professor Odame said in the lecture that it has proven to be an effective antidote for Sickle Cell disease in all parts of the world, including Africa- though the media never reported this as it didn’t suit their agenda.
“Ghana is losing out if its Sickle Cell patients are not taking Hydroxyurea treatment. It’s an ideal drug for several reasons; it’s efficacious, it increases feudal hemoglobin, it reduces acute and chronic complications in Sickle Cell patients and it’s proven to be an effective treatment for sickle cell,” said Professor Odame.
He noted that “there’s evidence of studies done on Hydroxyurea in Africa which shows that Sickle Cell patients who take this have fewer infections than those who don’t, adding that the treatment is seven times more effective in preventing strokes in patients, particularly in children.
He further stated that It would be recalled that Vice President, Dr. Bawumia in 2021, announced that government will absorb the cost of Hydroxyurea, a modifying therapy for Sickle Cell patients under the National Health Insurance Scheme (NHIS).